Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Rank in Stocks #35
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Share Price
$419.17
Market Cap
$333.66B
Change (1 day)
0.50%
Change (1 year)
21.90%
Country
CH
Trade Roche Holding AG (ROG)

Category

Earnings for Roche Holding AG (ROG)
Earnings in Dec 2025 TTM: $21.39B
According to Roche Holding AG latest financial reports the company's current earnings are $21.39B. In 2019 the company made an earning of $17.17B, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Roche Holding AG from 2019 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $21.39B 12.07%
2021 $19.09B 11.13%
2019 $17.17B 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country